Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teaching at scale: a mixed-methods study of team-based learning analytics to enable early support in medical education.

BMC medical education·2026
Same author

Supportive kidney care in private practice nephrology: A quality improvement project.

Journal of the American Association of Nurse Practitioners·2026
Same author

The Diversity Imperative: A Comprehensive Approach to Transforming Mental Health Through Inclusive Practice and Policy.

The Nursing clinics of North America·2026
Same author

Faculty perceptions of AI-versus human-summarized narrative exit survey data across three nursing programs.

Nurse education in practice·2025
Same author

Guidelines for Rapport-Building in Telehealth Videoconferencing: Interprofessional e-Delphi Study.

JMIR medical education·2025
Same author

Learning together: A quality improvement project on tandem training for dyad leadership partners in healthcare.

Healthcare management forum·2025
Same journal

Nanotechnology-Stem Cell Strategies in 3D Glioblastoma Organoid: Targeting Glioma Stem Cells Within a Complex Tumor Microenvironment.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Developing functional assays for BRCA1 unclassified variants.

Michelle Webb1

  • 1Faculty of Medical and Human Sciences, Medical Genetics Research Group, The University of Manchester, Manchester, UK.

Methods in Molecular Biology (Clifton, N.J.)
|August 20, 2010
PubMed
Summary
This summary is machine-generated.

Developing new assays to identify harmful BRCA1 gene mutations can prevent unnecessary surgeries for women with a family history of breast cancer. This research focuses on how mutations affect BRCA1 protein interactions and DNA binding.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Related Experiment Videos

Last Updated: Jun 10, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Family history of breast cancer is often linked to BRCA1/BRCA2 gene mutations.
  • Genetic testing for these mutations impacts life-altering decisions, including preventive surgeries.
  • Not all identified mutations necessarily increase breast cancer risk.

Purpose of the Study:

  • To develop assays for determining which BRCA1 mutations adversely affect protein function.
  • To prevent unnecessary prophylactic surgeries in women with a family history of breast cancer.
  • To understand the functional impact of missense mutations in BRCA1.

Main Methods:

  • Developing assays to assess the functional impact of BRCA1 mutations.
  • Focusing on how missense mutations affect BRCA1 protein interactions.
  • Investigating the effect of mutations on BRCA1's interaction with DNA.

Main Results:

  • Identifying specific BRCA1 mutations that disrupt protein function.
  • Establishing a basis for an assay to predict cancer risk from mutations.
  • Understanding the role of BRCA1 interactions in cell-cycle and DNA damage response.

Conclusions:

  • Functional assays are crucial for accurate breast cancer risk assessment in mutation carriers.
  • Distinguishing pathogenic from benign mutations can guide clinical decisions.
  • This research aims to refine genetic testing interpretation for BRCA1 mutations.